Shanghai INT Medical Instruments Co., Ltd.

SEHK:1501 Stock Report

Market Cap: HK$5.2b

Shanghai INT Medical Instruments Future Growth

Future criteria checks 5/6

Shanghai INT Medical Instruments is forecast to grow earnings and revenue by 27.2% and 28.7% per annum respectively. EPS is expected to grow by 26.4% per annum. Return on equity is forecast to be 14.7% in 3 years.

Key information

27.2%

Earnings growth rate

26.4%

EPS growth rate

Medical Equipment earnings growth39.9%
Revenue growth rate28.7%
Future return on equity14.7%
Analyst coverage

Low

Last updated19 Mar 2024

Recent future growth updates

No updates

Recent updates

Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

Jul 14
Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital

Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year

May 17
Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year

Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture

Nov 26
Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture

Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return

Aug 16
Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return

Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital

Apr 24
Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital

Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield

Apr 05
Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield

What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Mar 15
What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Jan 28
Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?

Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today

Dec 28
Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today

Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?

Dec 02
Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?

Earnings and Revenue Growth Forecasts

SEHK:1501 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,6643312213321
12/31/20251,2822601602681
12/31/2024979199462001
6/30/202480516727217N/A
3/31/2024779160-13197N/A
12/31/2023753152-53178N/A
9/30/2023727155-101175N/A
6/30/2023700159-149172N/A
3/31/2023643144-128176N/A
12/31/2022586130-108180N/A
9/30/2022548137-119152N/A
6/30/2022509143-129124N/A
3/31/2022487143-18098N/A
12/31/2021465143-23073N/A
9/30/2021416124-18373N/A
6/30/2021367105-13573N/A
3/31/2021363113-6584N/A
12/31/2020358121696N/A
9/30/2020341121N/AN/AN/A
6/30/2020323120N/AN/AN/A
3/31/2020305110N/AN/AN/A
12/31/20192861001892N/A
12/31/2018203582166N/A
12/31/201713841N/A39N/A
12/31/201610634N/A39N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1501's forecast earnings growth (27.2% per year) is above the savings rate (2.3%).

Earnings vs Market: 1501's earnings (27.2% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).

High Growth Earnings: 1501's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1501's revenue (28.7% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 1501's revenue (28.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1501's Return on Equity is forecast to be low in 3 years time (14.7%).


Discover growth companies